Litcius/Paper detail

MASLD and MASH: how a change of nomenclature may impact our approach in treating liver disease

Kelly Dale, Yasmeen Fallouh, Naim Alkhouri

2024Expert Opinion on Investigational Drugs13 citationsDOI

Abstract

1. Nonalcoholic fatty liver disease (NAFLD) is the world’s leading cause of chronic liver disease, with a global prevalence of approximately 30% [1]. NAFLD has been defined as the presence of steat...

Topics & Concepts

NomenclatureDiseaseMedicineTraditional medicineBiologyInternal medicineZoologyTaxonomy (biology)Liver Disease Diagnosis and TreatmentLiver Disease and TransplantationHepatitis C virus research